Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateTimeSourceHeadlineSymbolCompany
07/01/202123:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
07/01/202123:30GlobeNewswire Inc.Intellia Therapeutics Highlights Strategic Priorities and Anticipated Development Milestones for 2021NASDAQ:NTLAIntellia Therapeutics Inc
19/12/202008:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
13/12/202001:00GlobeNewswire Inc.Intellia Therapeutics Achieves Normal Human Alpha-1 Antitrypsin Protein Levels in Non-Human Primates Through Targeted Gene In...NASDAQ:NTLAIntellia Therapeutics Inc
09/12/202022:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
09/12/202008:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
06/12/202002:00GlobeNewswire Inc.Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myel...NASDAQ:NTLAIntellia Therapeutics Inc
05/12/202008:01GlobeNewswire Inc.Intellia Therapeutics Announces Closing of $201 Million Public Offering of Common Stock, Including Full Exercise of Underwrit...NASDAQ:NTLAIntellia Therapeutics Inc
04/12/202010:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
03/12/202008:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTLAIntellia Therapeutics Inc
02/12/202013:30GlobeNewswire Inc.Intellia Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:NTLAIntellia Therapeutics Inc
01/12/202009:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTLAIntellia Therapeutics Inc
01/12/202008:03Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:NTLAIntellia Therapeutics Inc
01/12/202008:01GlobeNewswire Inc.Intellia Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:NTLAIntellia Therapeutics Inc
11/11/202023:30GlobeNewswire Inc.Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease TreatmentsNASDAQ:NTLAIntellia Therapeutics Inc
09/11/202023:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
09/11/202023:30GlobeNewswire Inc.Intellia Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyre...NASDAQ:NTLAIntellia Therapeutics Inc
07/11/202008:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
06/11/202001:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
05/11/202023:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
05/11/202023:30GlobeNewswire Inc.Intellia Therapeutics Announces Third Quarter 2020 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
29/10/202022:30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2020 Earnings and Company UpdatesNASDAQ:NTLAIntellia Therapeutics Inc
19/10/202023:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
19/10/202022:30GlobeNewswire Inc.Intellia Therapeutics Receives Authorization to Initiate Phase 1 Clinical Trial of NTLA-2001 for Transthyretin Amyloidosis (...NASDAQ:NTLAIntellia Therapeutics Inc
10/10/202007:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
08/10/202007:20GlobeNewswire Inc.Intellia Therapeutics Congratulates Co-Founder Jennifer Doudna On Winning the 2020 Nobel Prize in Chemistry for Inventing the...NASDAQ:NTLAIntellia Therapeutics Inc
06/10/202007:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
06/10/202007:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
05/10/202022:30GlobeNewswire Inc.Intellia Therapeutics Names John F. Crowley to Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
29/09/202022:20GlobeNewswire Inc.Intellia Therapeutics Presents New Preclinical Data Showing Persistent In Vivo Editing and Durability of Effect Following CRI...NASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Your Recent History

Delayed Upgrade Clock